Influence of socioeconomic status on the quality of prescribing in the elderly - A population based study

British Journal of Clinical Pharmacology

Volumn 58, Issue 5, 2004, Pages 496-502

  Odubanjo, Enitan ^a   Bennett, Kathleen ^a   Feely, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Elderly; Pharmacoepidemiology; Quality prescribing; Socioeconomic status

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; DIAZEPAM; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXEPIN; GENERIC DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; SULFONYLUREA DERIVATIVE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VASODILATOR AGENT; WARFARIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMA; DIURETIC THERAPY; EVIDENCE BASED MEDICINE; FALLING; FRACTURE; GENERAL PRACTICE; GERIATRIC PATIENT; HEALTH CARE QUALITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPOGLYCEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SEDATION; SIDE EFFECT; SOCIOECONOMICS;

AGED; COHORT STUDIES; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; IRELAND; MALE; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PRESCRIPTIONS, DRUG; QUALITY OF HEALTH CARE; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS;

EID: 9144268960     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02179.x     Document Type: Article

References (31)

1. Rochon P, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096-9.
2. Buckley BM. Healthy ageing: ageing safely. Eur Heart J 2001; 3(Suppl. N): N6-10.
3. Hanlon JT, Schameder KE, Boult C, Artz MB, Gross CR, Fillenbaum GG, Ruby CM, Garrad J. Use of inappropriate prescription drugs by older people. J Am Geriatrics Soc 2002; 50: 26-34.
4. Straand J, Rokstad KS. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. A report from the Møre and Romsdal Prescription Study. Family Prac 1999; 16: 380-8.
5. Bateman DN, Eccles M, Campbell M, Soutter J, Roberts SJ, Smith JM. Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Prac 1996; 46: 20-5.
6. Oborne CA, Batty GM, Maskey V, Swift CG, Jackson SHD. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91-7.
7. Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: a Delphi consultation study. BMJ 2000; 321: 1-5.
8. Gribben B, Coster G, Pringle M, Simon J. Quality of care indicators for population based primary care in New Zealand. N Z Med J 2002; 115: 163-6.
9. Robertson J, Fryer JL, O'Connell DI, Smith AJ, Henry DA. Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators. Med J Aust 2002; 176: 419-24.
10. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001; 135: 703-10.
11. Lawrence M, Olesen F. Indicators of quality in health care. Eur J Gen Pract 1997; 3: 103-8.
12. Mamdani MM, Tu K, Austin PC, Alter DA. Influence of socioeconomic status on drug selection for the elderly in Canada. Ann Pharmacother 2002; 36: 804-8.
13. Worral A, Rea J, Ben-shlomo Y. Counting the cost of social disadvantage in primary care: retrospective analysis of patient data. BMJ 1997; 314: 520-3.
14. Hays DI. Socioeconomic status and health status: a study of males in the Canada health survey. Soc Sci Med 1998; 27 (12): 1317-25.
15. Knesebeck O, Luschen G, Cockerham WC, Siegrist J. Socioeconomic status and health among the aged in the United States and Germany: a comparative cross-sectional study. Soc Sci Med 2003; 57: 1643-52.
16. Kunst AE, Groenhof F, Makenbach JP. The EU Working Group on Socioeconomic Inequalities in Health. Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies. BMJ 1998; 316: 1636-41.
17. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997; 157: 1531-6.
18. British National Formulary (BNF) - Number 45. Pharmaceutical Press, Oxford, UK, March 2003.
19. Gray J, Majeed A, Ferry S, Rowlands G. Identifying patients with ischaemic heart disease in general practice - cross sectional study of paper and computerised medical records. BMJ 2000; 321: 548-50.
20. Feely J, Chan R, McManus J, O'Shea B. The influence of hospital based prescribers on prescribing in general practice. Pharmacoeconomics 1999; 16: 175-81.
21. General Medical Services (Payments) Board. Annual report for the year ended 31st December 2002.
22. WHO. Collaborating Centre for Drug Statistics Methodology (ATC Index with DDDs). Oslo, Norway 2003.
23. Heart Protection Study Collaborative Group. MRC/BHF Heart protection Study on cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo controlled trial. Lancet 2002; 360: 7-22.
24. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-30.
25. Macintyre K, Stewart S, Chalmers J, Pell J, Finlayson A, Boyd J, Redpath A, McMurray J, Campbell S. Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population-based analysis. BMJ 2001; 322: 1152-3.
26. Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H. Effect on socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community event register. BMJ 1997; 314: 541.
27. Wilson RPH, Hatcher J, Barton S, Walley T. The Association of Some Practice Characteristics with Antibiotic Prescribing. Pharmacoepidemiol Drug Safety 1999; 8: 15-21.
28. Aparasu RR, Mort J. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 338-46.
29. Pick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-24.
30. Field TS, Curwitz IH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161: 1629-34.
31. Prosser H, Almond S, Walley T. Influence on GP's decision to prescribe new drugs - the importance of who says what. Family Prac 2003; 20: 61-8.